7 min. Read

Novartis shares results from Pear schizophrenia DTx study

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

E&O Fridays.

If you are reading this in

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases

Help me get ahead. $200/year

Newsletters

Big Health’s 2024 revenue shrinks. 2025: Runway worries.

9.26.25

5 min. Read

Kavira Health pricing. What did Swing Therapeutics buy? PFS Comments.

9.18.25

7 min. Read

Cerebral’s $25M M&A. Amazon-Fay. Oshi growth numbers.

9.12.25

4 min. Read

Letters to CMS: DMHT codes, MDPP pricing, more. Plus: Unannounced funding.

9.05.25

6 min. Read

Pricing updates: Teladoc, Maven, Garner, Kaia and more

8.29.25

4 min. Read

Pricing for Aetna Transform and 2nd.MD. Teladoc on PFS. Plus: Secret funding.

8.22.25

7 min. Read

New wearable BP 510(k) sheds light on Whoop-FDA. Trials: BetterHelp, Click, DynamiCare, Axena, Kaiser

8.08.25

8 min. Read

CMS RFI review: 12 ideas from health tech cos

7.25.25

10 min. Read

CMS proposes changes to digital mental health G codes, four year test of online DPP reimbursement.

7.16.25

10 min. Read

Digital mental health G code adoption “slow and challenging”

7.11.25

9 min. Read

Novartis shares results from Pear schizophrenia DTx study

E&O Fridays.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.